Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

84.67 -0.67 (-0.79%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
What 4 Analyst Ratings Have To Say About DexCom
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with... 
Via Benzinga
Dexcom Q3 Earnings Beat Street, Raises FY21 Outlook Ahead Of G7 Launch
Dexcom Inc's (NASDAQ: DXCM) Q3 adjusted EPS of $0.89 though lower than $0.94 posted a year ago, came in sharply above the consensus of $0.63. Sales increased... 
Via Benzinga
Topics Earnings
Exposures Financial
10 Biggest Price Target Changes For Friday
Oppenheimer boosted the price target on Apple Inc. (NASDAQ:A... 
Via Benzinga
DexCom Inc (DXCM) Q3 2021 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: DexCom Q3 Earnings
DexCom (NASDAQ:DXCM) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:02 PM. Here's what investors need to know about the announcement. Earnings DexCom... 
Via Benzinga
Analyst Ratings For DexCom
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with... 
Via Benzinga
Expert Ratings For DexCom
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following an... 
Via Benzinga
Dexcom Pops Closer To A Record High After Crushing Third-Quarter Forecasts
Dexcom easily topped Wall Street's third-quarter forecasts late Thursday. 
Via Investor's Business Daily
Dexcom Reports Third Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
2 Unstoppable Stocks to Buy and Hold for Decades
These are investments that you won't need to worry about. 
Via The Motley Fool
Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time
From Dexcom, Inc.
Via Business Wire
1 Supercharged Healthcare Stock to Buy Right Now
The stock isn't a household name, but it's generated multibagger returns over the past five years alone. 
Via The Motley Fool
Ignore GameStop: Here Are 2 Better Stocks
The performance of these two companies isn't detached from their financial results. 
Via The Motley Fool
Exposures COVID-19
Dexcom Insider Sold Over $3.87 Million In Company Stock
Steven R Pacelli, Managing Dir. And Dexcom Ventures at Dexcom (NASDAQ:DXCM), made a large insider sell on September 23, according to a new SEC filing. What Happened: A Form 4... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Dexcom Insider Sold Over $3.24 Million In Company Stock
Kevin R Sayer, CEO And President at Dexcom (NASDAQ:DXCM), made a large insider sell on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S.... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Notable Dexcom Insider Makes $3.06 Million Sale
Andrew K Balo, * at Dexcom (NASDAQ:DXCM), made a large insider sell on September 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Desperate for Solutions, Diabetes and Obesity Healthcare Sectors Find Answers, Hope in Innovative Tech
Via Investor Brand Network
Exposures COVID-19
Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy
From Dexcom, Inc.
Via Business Wire
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
Notable Dexcom Insider Makes $10.22 Million Sale
Quentin S Blackford, Chief Operating Officer at Dexcom (NASDAQ:DXCM), made a large insider sell on September 10, according to a new SEC filing. What Happened: A Form 4 filing... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (... 
Via Benzinga
Dexcom Announces Upcoming Virtual Conference Presentations
From DexCom, Inc.
Via Business Wire
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Moderna And DexCom Lead The Nasdaq-100
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.17% to... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Exposures COVID-19
Pool, Dexcom Lead Five Stocks Showing Tight, Bullish Action Near Buy Points
Tight trading is a bullish sign. Pool, Dexcom lead five stocks trading tightly near buy points. 
Via Investor's Business Daily
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... 
Via Benzinga
Exposures COVID-19 Product Safety
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.